Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Cash Flows

v2.4.0.8
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Cash flows from operating activities:    
Net earnings (loss) $ 110,836 $ (15,934)
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities    
Depreciation and amortization 50,220 49,892
Stock compensation expense 27,252 18,417
Impairment loss 0 28,033
Gain (Loss) on Sale of Notes Receivable 0 17,880
Deferred income taxes 1,626 (19,318)
Changes in assets and liabilities    
Premium and related receivables (58,587) (139,414)
Other current assets (19,133) (23,487)
Other assets (65,397) 1,918
Medical claims liabilites 103,895 374,046
Unearned revenue 7,976 122,077
Accounts payable and accrued expenses 48,840 (59,872)
Other operating activities 4,142 (11,196)
Net cash provided by (used in) operating activities 211,670 307,282
Cash flows from investing activities:    
Capital expenditures (46,383) (70,601)
Purchases of investments (666,016) (501,958)
Sales and maturities of investments 451,034 434,009
Investments in acquisitions, net of cash acquired (62,773) 0
Net cash used in investing activities (324,138) (138,550)
Cash flows from financing activities:    
Proceeds from exercise of stock options 7,674 11,686
Proceeds from borrowings 30,000 215,000
Payment of long-term debt (40,842) (177,422)
Proceeds from stock offering 15,225 0
Excess tax benefits from stock compensation 1,140 6,049
Common stock repurchases (5,677) (2,154)
Contribution from noncontrolling interest 5,864 1,032
Debt issue costs (3,587) 0
Net cash provided by financing activities 9,797 54,191
Net decrease in cash and cash equivalents (102,671) 222,923
Cash and cash equivalents, beginning of period 843,952 573,698
Cash and cash equivalents, end of period 741,281 796,621
Supplemental disclosures of cash flow information:    
Interest paid 16,738 12,127
Income taxes paid 40,921 34,001
Equity issued in connection with acquisition $ 75,425 $ 0